23andMe Holding Co (ME)
0.5452
-0.01
(-2.33%)
USD |
NASDAQ |
May 31, 16:00
0.5452
0.00 (0.00%)
After-Hours: 20:00
23andMe Cash from Investing (Quarterly): -2.146M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.146M |
| December 31, 2023 | -2.012M |
| September 30, 2023 | -2.773M |
| June 30, 2023 | -2.695M |
| March 31, 2023 | -3.288M |
| December 31, 2022 | -3.066M |
| September 30, 2022 | -2.051M |
| June 30, 2022 | -2.90M |
| Date | Value |
|---|---|
| March 31, 2022 | -3.197M |
| December 31, 2021 | -95.82M |
| September 30, 2021 | -7.729M |
| June 30, 2021 | -1.387M |
| March 31, 2021 | -0.789M |
| December 31, 2020 | -0.744M |
| September 30, 2020 | -1.055M |
| June 30, 2020 | -3.948M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-95.82M
Minimum
Dec 2021
-0.744M
Maximum
Dec 2020
-8.475M
Average
-2.734M
Median
Cash from Investing (Quarterly) Benchmarks
| RadNet Inc | -60.94M |
| DermTech Inc | 7.834M |
| iSpecimen Inc | 1.937M |
| Sera Prognostics Inc | -5.689M |
| Progyny Inc | 19.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.78M |
| Cash from Financing (Quarterly) | 2.00M |
| Free Cash Flow | -173.98M |
| Free Cash Flow Per Share (Quarterly) | -0.0575 |
| Free Cash Flow to Equity (Quarterly) | -27.95M |
| Free Cash Flow to Firm (Quarterly) | -27.95M |
| Free Cash Flow Yield | -67.05% |